drugset / Trial / NCT00557466
A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the dose response relationship among four doses of indacaterol as well as placebo delivered via the TWISTHALER® device.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 62.5 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 125 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 250 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 500 ug | Inhaled |
| Background | Salbutamol | Unknown | 90 ug | Inhaled |
| Background | Salbutamol | Unknown | 100 ug | Inhaled |